Full Access with Signal8 Pro, $49/mo billed annually.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Sector: Agricultural Chemicals
Industry: Biotechnology
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 76.43M shares outstanding
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name.
The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cornelis (Carlo) Broos
Chief Financial Officer
Greg Gocal, Ph.D.
Chief Scientific Officer and Executive Vice President
Jason Stokes, Esq.
Chief Administrative Officer, General Counsel and Corporate Secretary
Noel Sauer, Ph.D.
Senior Vice President, Research
Employees
118
Country
US
Sector
Healthcare
Website
cibus.com
Loading congressional disclosures…
based on 76.43M shares outstanding
30d Avg
141.92K
60d Avg
129.74K
90d Avg
172.48K